Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / EYPT - EyePoint Pharmaceuticals GAAP EPS of -$0.56 in-line revenue of $9.3M misses by $0.59M


EYPT - EyePoint Pharmaceuticals GAAP EPS of -$0.56 in-line revenue of $9.3M misses by $0.59M

EyePoint Pharmaceuticals press release (NASDAQ:EYPT): Q1 GAAP EPS of -$0.56 in-line. Revenue of $9.3M (+27.4% Y/Y) misses by $0.59M. Cash and investments at March 31, 2022 totaled $190.8 million compared to $211.6 million at December 31, 2021. We expect the cash and investments on hand on March 31, 2022 and expected net cash inflows from our product sales will enable us to fund our current and planned operations into the second half of 2024.

For further details see:

EyePoint Pharmaceuticals GAAP EPS of -$0.56 in-line, revenue of $9.3M misses by $0.59M
Stock Information

Company Name: EyePoint Pharmaceuticals Inc.
Stock Symbol: EYPT
Market: NASDAQ
Website: eyepointpharma.com

Menu

EYPT EYPT Quote EYPT Short EYPT News EYPT Articles EYPT Message Board
Get EYPT Alerts

News, Short Squeeze, Breakout and More Instantly...